2m 2m 2m 2m 2m 2m 2m
INNATE SP ADS (IPHA)
NASDAQ
$1.80+$0.04 (+2.22%)
Price as of Jun 03, 2026 7:50 PM EDT- $171.8MMarket Cap
- -14.55%1-Year Change
- BiotechnologyIndustry
INNATE SP ADS (IPHA)
$1.80+$0.04 (+2.22%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.0M -55.25% | 20.1M -67.36% | 61.6M +6.88% | 57.7M +133.47% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 9.0M -55.25% | 20.1M -67.36% | 61.6M +6.88% | 57.7M +133.47% | |
Sales and Marketing Expense | 47,000 -99.76% | 19.7M +7.81% | 18.3M -18.49% | 22.4M -12.10% | |
Research and Development Expense | -43.6M -16.08% | -52.0M -7.22% | -56.0M +8.44% | -51.7M +9.91% | |
Depreciation and Amortization Expense | 1.4M -30.59% | 2.0M -60.83% | 5.1M -88.79% | 45.4M +887.92% | |
Total Operating Expenses | 19.4M -1.63% | 19.7M +7.81% | 18.3M -18.49% | 22.4M -12.10% | |
Operating Profit | -54.0M +4.72% | -51.6M +307.10% | -12.7M -77.94% | -57.4M +20.07% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -440,000 -22.26% | -566,000 -11.56% | -640,000 +122.22% | -288,000 -7.69% | |
Interest Income and Expense and Net | -440,000 -22.26% | -566,000 -11.56% | -640,000 +122.22% | -288,000 -7.69% | |
Total Nonoperating Income and Expense | 13,000 +18.18% | 11,000 0.00% | 11,000 -81.36% | 59,000 -81.09% | |
Income before Taxes | -49.2M -0.59% | -49.5M +553.51% | -7.6M -86.97% | -58.1M +10.02% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -49.2M -0.59% | -49.5M +553.51% | -7.6M -86.97% | -58.1M +10.02% | |
Net Income from Continuing Operations Applicable to Common | -49.2M -0.59% | -49.5M +553.51% | -7.6M -86.97% | -58.1M +10.02% | |
Basic EPS and Net Income | -0.55 -9.84% | -0.61 +577.78% | -0.09 -87.67% | -0.73 +10.61% | |
Diluted EPS and Net Income | -0.55 -9.84% | -0.61 +577.78% | -0.09 -87.67% | -0.73 +10.61% | |
Basic Weighted Average Shares | 89.6M +10.54% | 81.1M +0.74% | 80.5M +1.02% | 79.6M +0.12% | |
Diluted Weighted Average Shares | 89.6M +10.54% | 81.1M +0.74% | 80.5M +1.02% | 79.6M +0.12% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 28.1M -57.69% | 66.4M -5.96% | 70.6M -16.17% | 84.2M -18.82% | |
Short-Term Investments | 6.2M -56.74% | 14.4M -34.21% | 21.9M +26.60% | 17.3M +7.34% | |
Cash and Cash Equivalents and Short-Term Investments | 34.3M -57.52% | 80.8M -12.64% | 92.5M -8.90% | 101.5M -15.31% | |
Total Current Assets | 46.7M -45.52% | 85.7M -42.07% | 148.0M +5.85% | 139.8M +1.14% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 8.5M -16.04% | |
Total Long-Term Assets | 16.0M -36.77% | 25.3M -30.03% | 36.2M -46.82% | 68.0M -47.36% | |
Total Assets | 62.7M -43.53% | 111.1M -39.71% | 184.2M -11.39% | 207.9M -22.29% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 36.6M +11.12% | 33.0M -16.79% | 39.6M -4.11% | 41.3M -48.25% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 47.8M -31.01% | 69.2M -25.27% | 92.7M -17.55% | 112.4M +40.17% | |
Total Liabilities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | -21.7M -345.69% | 8.8M -82.98% | 51.9M -4.16% | 54.2M -49.60% | |
Total Shares Outstanding | 93.7M +11.80% | 83.8M +3.67% | 80.9M +1.66% | 79.5M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -52.8M +665.01% | -6.9M -78.82% | -32.6M +69.98% | -19.2M -67.23% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 7.3M -20.77% | 9.2M -55.41% | 20.6M +999.15% | 1.9M +304.69% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.1M +201.03% | -6.0M +205.60% | -2.0M +7.55% | -1.8M -106.82% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -599.76% +133.98% | -256.32% +1,147.14% | -20.55% -79.36% | -99.57% -48.57% | |
Return on Assets | -56.60% +68.89% | -33.51% +767.78% | -3.86% -84.20% | -24.45% +33.07% | |
Return on Equity | 764.21% +569.11% | -162.91% +1,041.13% | -14.28% -80.15% | -71.91% +79.36% | |
Revenue Growth | -55.25% -17.98% | -67.36% -1,079.28% | 6.88% -94.85% | 133.47% +305.54% | |
Current Ratio | 1.27 -50.98% | 2.60 -30.38% | 3.73 +10.39% | 3.38 +95.45% | |
Cash Ratio | 0.77 -61.92% | 2.01 +13.01% | 1.78 -12.57% | 2.04 +56.88% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow